EMPIRE BIO A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About EMPIRE BIO A/S
EMPIRE BIO A/S (CVR number: 12627343) is a company from KØBENHAVN. The company recorded a gross profit of 5909.4 kDKK in 2024. The operating profit was -410.1 kDKK, while net earnings were -326.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -5.6 %, which can be considered poor and Return on Equity (ROE) was -7.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 62.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. EMPIRE BIO A/S's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 6 733.64 | 6 071.77 | 6 158.89 | 6 139.57 | 5 909.41 |
EBIT | 621.09 | 201.88 | -82.32 | - 271.01 | - 410.05 |
Net earnings | 451.62 | 125.29 | -84.64 | - 210.01 | - 326.67 |
Shareholders equity total | 4 729.12 | 4 854.41 | 4 769.77 | 4 559.75 | 4 233.08 |
Balance sheet total (assets) | 12 336.68 | 10 989.72 | 8 739.08 | 7 421.99 | 6 996.69 |
Net debt | -6 139.38 | -4 343.84 | -2 547.65 | -1 270.87 | - 487.66 |
Profitability | |||||
EBIT-% | |||||
ROA | 5.5 % | 1.7 % | -0.8 % | -3.4 % | -5.6 % |
ROE | 7.5 % | 2.6 % | -1.8 % | -4.5 % | -7.4 % |
ROI | 10.0 % | 4.0 % | -1.7 % | -5.8 % | -9.2 % |
Economic value added (EVA) | 229.26 | 228.91 | -88.33 | - 321.68 | - 482.94 |
Solvency | |||||
Equity ratio | 39.0 % | 45.1 % | 56.0 % | 63.3 % | 62.5 % |
Gearing | |||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.9 | 0.9 | 0.9 | 0.8 | 0.6 |
Current ratio | 0.9 | 0.9 | 1.0 | 0.8 | 0.7 |
Cash and cash equivalents | 6 139.38 | 4 343.84 | 2 547.65 | 1 270.87 | 487.66 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.